Use of pyruvylglycine to treat ischemia/reperfusion injury following myocardial infarction
US5508308A · kind A · utility
8Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 1995 |
| Grant date | Apr 16, 1996 |
| Priority date | — |
| Expiry date | Jan 31, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/195
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic method is provided to reduce ischemia/reperfusion injury to the heart muscle by perfusing pyruvylglycine into the circulatory system of a patient who has had a heart attack or suffered coronary occlusion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.